This study investigated Toxoplasma gondii infections in chimpanzees. One previously infected chimpanzee showed no symptoms, while a new infection in the second chimpanzee caused illness and detectable infectivity.
Area of Science:
Veterinary Parasitology
Infectious Diseases
Primate Research
Background:
Toxoplasma gondii is a widespread parasite with a complex life cycle.
Understanding transmission dynamics in intermediate hosts like chimpanzees is crucial for public health.
Previous infections can influence the host response to subsequent parasitic challenges.
Purpose of the Study:
To investigate the clinical and parasitological outcomes of oral Toxoplasma gondii oocyst infection in chimpanzees.
To assess the infectivity of experimentally infected chimpanzees.
To explore the potential role of chimpanzees in the transmission cycle of Toxoplasma gondii.
Main Methods:
Two chimpanzees were orally administered viable Toxoplasma gondii oocysts from infected cats.
Serological testing (dye test) was performed before and after inoculation.
Clinical signs, oocyst shedding, and infectivity of biological samples (blood, lymph nodes, muscle) were monitored.
Infectivity was assessed by inoculating mice with chimpanzee samples.
Main Results:
The previously infected chimpanzee (positive dye test) showed no adverse effects or oocyst shedding.
The naive chimpanzee (negative dye test) developed a positive antibody response, clinical signs of illness, and infectivity in blood, lymph nodes, and muscle tissue.
No oocysts were detected in the feces of either chimpanzee during the six-week observation period.
Conclusions:
Chimpanzees can serve as intermediate hosts for Toxoplasma gondii, exhibiting varying responses based on prior infection status.
Experimental infection demonstrated the potential for chimpanzees to harbor and transmit the parasite without shedding oocysts.
The findings contribute to understanding the epidemiology and transmission of toxoplasmosis in primates and humans.